AFBI vs EXAS · P/E 16, $137.1M cap vs rev $2.76B
Affinity Bancshares Inc (AFBI) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Affinity Bancshares Inc (AFBI) is a banks - regional company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
AFBI does not have a complete income-statement cache yet.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
AFBI currently screens at market cap $137.1M and trailing P/E 16.4. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the AFBI and EXAS stock pages for the full models.
Not investment advice.